Bringing the fundamentals into focus…
Back to Armata Pharmaceuticals, Inc.
How Armata Pharmaceuticals, Inc. stacks up
ARMP · against 120 other Healthcare companies of similar size
Profitability
15/ 100
Below the middle of the pack.
Ranked #82 of 121 · scores higher than 30% of peers
Bars: peers in each 10-point band of the profitability score23 peers with a profitability score of 10–19, including ARMP · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 100% of peers. Return on assets: -213.6% vs peer median 1.7%
- a lower return on invested capital: weaker than 83% of peers. Return on invested capital: -30.7% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = ARMP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ARMP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 90 reported | -30.7% | -14.7% | 40% | 33% | |
| Operating marginHigher is better · 111 reported | Not reported | -6.9% | — | — | 33% |
| Return on assetsHigher is better · 126 reported | -213.6% | -6.0% | 0% | 33% | |
| Return on equityHigher is better · 117 reported | Not reported | -11.7% | — | — | Context only |
| Gross marginHigher is better · 128 reported | -217.4% | 42.3% | 1% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ARMP| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 2 | 592M ILS (≈$160M) | 96 | 84 | |
| 3 | 157M USD | 95 | ||
| 4 | 144.4B KRW (≈$104M) | 88 | 56 | |
| 5 | 244.2B KRW (≈$176M) | 83 | 72 | |
| 77 | 165M USD | 18 | 50 | |
| 79 | 207M USD | 17 | 41 | |
| 79 | 142M USD | 17 | 45 | |
| 81 | 83.4B KRW (≈$60M) | 16 | 36 | |
| 82 | 115M USD | 15 | 8 | |
| 82 | 109M USD | 15 | 47 | |
| 82 | 107M USD | 15 | 31 | |
| 82 | 139M USD | 15 | 32 | |
| 86 | 186M USD | 14 | 43 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score